nodes	percent_of_prediction	percent_of_DWPC	metapath
Pemetrexed—ATIC—pes—peripheral nervous system neoplasm	0.0562	0.337	CbGeAlD
Pemetrexed—ATIC—forelimb—peripheral nervous system neoplasm	0.0284	0.17	CbGeAlD
Pemetrexed—ATIC—ganglion—peripheral nervous system neoplasm	0.0154	0.092	CbGeAlD
Pemetrexed—GART—trigeminal ganglion—peripheral nervous system neoplasm	0.0111	0.0666	CbGeAlD
Pemetrexed—GART—parotid gland—peripheral nervous system neoplasm	0.0105	0.0628	CbGeAlD
Pemetrexed—GART—Nucleotide metabolism—NME1—peripheral nervous system neoplasm	0.00998	0.103	CbGpPWpGaD
Pemetrexed—ATIC—Nucleotide metabolism—NME1—peripheral nervous system neoplasm	0.00692	0.0712	CbGpPWpGaD
Pemetrexed—ATIC—brainstem—peripheral nervous system neoplasm	0.00667	0.04	CbGeAlD
Pemetrexed—DHFR—trigeminal ganglion—peripheral nervous system neoplasm	0.00506	0.0304	CbGeAlD
Pemetrexed—GART—cerebellum—peripheral nervous system neoplasm	0.00484	0.029	CbGeAlD
Pemetrexed—SLC29A1—trigeminal ganglion—peripheral nervous system neoplasm	0.00459	0.0275	CbGeAlD
Pemetrexed—DCK—trigeminal ganglion—peripheral nervous system neoplasm	0.00438	0.0263	CbGeAlD
Pemetrexed—DCK—parotid gland—peripheral nervous system neoplasm	0.00413	0.0248	CbGeAlD
Pemetrexed—DCK—Retinoblastoma (RB) in Cancer—BARD1—peripheral nervous system neoplasm	0.00404	0.0416	CbGpPWpGaD
Pemetrexed—SLC46A1—cerebellum—peripheral nervous system neoplasm	0.00393	0.0236	CbGeAlD
Pemetrexed—DCK—Nucleotide metabolism—NME1—peripheral nervous system neoplasm	0.0036	0.037	CbGpPWpGaD
Pemetrexed—ATIC—cerebellum—peripheral nervous system neoplasm	0.00329	0.0197	CbGeAlD
Pemetrexed—DHFR—Retinoblastoma (RB) in Cancer—BARD1—peripheral nervous system neoplasm	0.00325	0.0334	CbGpPWpGaD
Pemetrexed—TYMS—Retinoblastoma (RB) in Cancer—BARD1—peripheral nervous system neoplasm	0.00284	0.0292	CbGpPWpGaD
Pemetrexed—TYMS—Nucleotide metabolism—NME1—peripheral nervous system neoplasm	0.00252	0.026	CbGpPWpGaD
Pemetrexed—SLC46A1—Defective AMN causes hereditary megaloblastic anemia 1—SLC2A1—peripheral nervous system neoplasm	0.00252	0.0259	CbGpPWpGaD
Pemetrexed—TYMS—Vitamin A—Tretinoin—peripheral nervous system neoplasm	0.00251	0.127	CbGdCrCtD
Pemetrexed—TYMS—Vitamin A—Isotretinoin—peripheral nervous system neoplasm	0.00251	0.127	CbGdCrCtD
Pemetrexed—TYMS—cerebellum—peripheral nervous system neoplasm	0.00223	0.0134	CbGeAlD
Pemetrexed—DHFR—cerebellum—peripheral nervous system neoplasm	0.00221	0.0132	CbGeAlD
Pemetrexed—SLC29A1—cerebellum—peripheral nervous system neoplasm	0.002	0.012	CbGeAlD
Pemetrexed—GART—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.00194	0.0199	CbGpPWpGaD
Pemetrexed—DCK—cerebellum—peripheral nervous system neoplasm	0.00191	0.0115	CbGeAlD
Pemetrexed—TYMS—Vitamin A—Alitretinoin—peripheral nervous system neoplasm	0.0019	0.0962	CbGdCrCtD
Pemetrexed—TYMS—Alitretinoin—Isotretinoin—peripheral nervous system neoplasm	0.00176	0.0887	CbGdCrCtD
Pemetrexed—TYMS—Tretinoin—Isotretinoin—peripheral nervous system neoplasm	0.00176	0.0887	CbGdCrCtD
Pemetrexed—TYMS—Alitretinoin—Tretinoin—peripheral nervous system neoplasm	0.00176	0.0887	CbGdCrCtD
Pemetrexed—TYMS—Isotretinoin—Tretinoin—peripheral nervous system neoplasm	0.00176	0.0887	CbGdCrCtD
Pemetrexed—GART—Folate Metabolism—TP53—peripheral nervous system neoplasm	0.00149	0.0154	CbGpPWpGaD
Pemetrexed—DHFR—Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation—AKT1—peripheral nervous system neoplasm	0.00143	0.0147	CbGpPWpGaD
Pemetrexed—DHFR—Defective AMN causes hereditary megaloblastic anemia 1—SLC2A1—peripheral nervous system neoplasm	0.00135	0.0139	CbGpPWpGaD
Pemetrexed—ATIC—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.00134	0.0138	CbGpPWpGaD
Pemetrexed—TYMS—Isotretinoin—Alitretinoin—peripheral nervous system neoplasm	0.00133	0.0673	CbGdCrCtD
Pemetrexed—TYMS—Tretinoin—Alitretinoin—peripheral nervous system neoplasm	0.00133	0.0673	CbGdCrCtD
Pemetrexed—GART—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.00131	0.0135	CbGpPWpGaD
Pemetrexed—TYMS—Integrated Pancreatic Cancer Pathway—NME1—peripheral nervous system neoplasm	0.00123	0.0127	CbGpPWpGaD
Pemetrexed—SLC29A1—Fluoropyrimidine Activity—TP53—peripheral nervous system neoplasm	0.00111	0.0115	CbGpPWpGaD
Pemetrexed—SLC46A1—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.00105	0.0108	CbGpPWpGaD
Pemetrexed—SLC46A1—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	0.00101	0.0104	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism of nitric oxide—AKT1—peripheral nervous system neoplasm	0.00099	0.0102	CbGpPWpGaD
Pemetrexed—GART—Metabolism—GNS—peripheral nervous system neoplasm	0.000946	0.00974	CbGpPWpGaD
Pemetrexed—ATIC—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.000907	0.00933	CbGpPWpGaD
Pemetrexed—GART—Metabolism—NME1—peripheral nervous system neoplasm	0.000907	0.00933	CbGpPWpGaD
Pemetrexed—GART—Metabolism—COX2—peripheral nervous system neoplasm	0.000873	0.00898	CbGpPWpGaD
Pemetrexed—SLC29A1—SLC-mediated transmembrane transport—SLC2A1—peripheral nervous system neoplasm	0.000831	0.00855	CbGpPWpGaD
Pemetrexed—SLC46A1—Folate Metabolism—TP53—peripheral nervous system neoplasm	0.000807	0.00831	CbGpPWpGaD
Pemetrexed—SLC29A1—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	0.000798	0.00821	CbGpPWpGaD
Pemetrexed—TYMS—Vinorelbine—Vincristine—peripheral nervous system neoplasm	0.000789	0.0399	CbGdCrCtD
Pemetrexed—TYMS—Podofilox—Etoposide—peripheral nervous system neoplasm	0.000788	0.0399	CbGdCrCtD
Pemetrexed—DHFR—Fluoropyrimidine Activity—TP53—peripheral nervous system neoplasm	0.000754	0.00776	CbGpPWpGaD
Pemetrexed—DHFR—E2F transcription factor network—CDKN2A—peripheral nervous system neoplasm	0.000717	0.00738	CbGpPWpGaD
Pemetrexed—SLC46A1—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.000707	0.00727	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.000698	0.00718	CbGpPWpGaD
Pemetrexed—TYMS—Fluoropyrimidine Activity—TP53—peripheral nervous system neoplasm	0.000658	0.00677	CbGpPWpGaD
Pemetrexed—ATIC—Metabolism—GNS—peripheral nervous system neoplasm	0.000656	0.00675	CbGpPWpGaD
Pemetrexed—ATIC—Metabolism—NME1—peripheral nervous system neoplasm	0.000629	0.00647	CbGpPWpGaD
Pemetrexed—TYMS—E2F transcription factor network—CDKN2A—peripheral nervous system neoplasm	0.000626	0.00644	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—GNS—peripheral nervous system neoplasm	0.00061	0.00628	CbGpPWpGaD
Pemetrexed—ATIC—Metabolism—COX2—peripheral nervous system neoplasm	0.000605	0.00623	CbGpPWpGaD
Pemetrexed—TYMS—Integrated Pancreatic Cancer Pathway—CHEK2—peripheral nervous system neoplasm	0.000604	0.00621	CbGpPWpGaD
Pemetrexed—TYMS—Circadian rythm related genes—TH—peripheral nervous system neoplasm	0.000594	0.00611	CbGpPWpGaD
Pemetrexed—GART—Metabolism—ENO2—peripheral nervous system neoplasm	0.000573	0.0059	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.000561	0.00577	CbGpPWpGaD
Pemetrexed—TYMS—Integrated Pancreatic Cancer Pathway—NTRK1—peripheral nervous system neoplasm	0.00055	0.00566	CbGpPWpGaD
Pemetrexed—DCK—Doxorubicin—Epirubicin—peripheral nervous system neoplasm	0.000546	0.0276	CbGdCrCtD
Pemetrexed—Dizziness—Topotecan—peripheral nervous system neoplasm	0.000546	0.000762	CcSEcCtD
Pemetrexed—Musculoskeletal discomfort—Vincristine—peripheral nervous system neoplasm	0.000545	0.000761	CcSEcCtD
Pemetrexed—TYMS—Vinblastine—Vincristine—peripheral nervous system neoplasm	0.000543	0.0274	CbGdCrCtD
Pemetrexed—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.000542	0.000756	CcSEcCtD
Pemetrexed—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.000542	0.000756	CcSEcCtD
Pemetrexed—Decreased appetite—Alitretinoin—peripheral nervous system neoplasm	0.00054	0.000753	CcSEcCtD
Pemetrexed—Gastrointestinal disorder—Alitretinoin—peripheral nervous system neoplasm	0.000536	0.000748	CcSEcCtD
Pemetrexed—Fatigue—Alitretinoin—peripheral nervous system neoplasm	0.000535	0.000747	CcSEcCtD
Pemetrexed—SLC46A1—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	0.000533	0.00548	CbGpPWpGaD
Pemetrexed—Leukopenia—Etoposide—peripheral nervous system neoplasm	0.000531	0.000742	CcSEcCtD
Pemetrexed—Constipation—Alitretinoin—peripheral nervous system neoplasm	0.000531	0.000741	CcSEcCtD
Pemetrexed—Pain—Alitretinoin—peripheral nervous system neoplasm	0.000531	0.000741	CcSEcCtD
Pemetrexed—Body temperature increased—Dactinomycin—peripheral nervous system neoplasm	0.000529	0.000739	CcSEcCtD
Pemetrexed—Abdominal pain—Dactinomycin—peripheral nervous system neoplasm	0.000529	0.000739	CcSEcCtD
Pemetrexed—Oedema—Cisplatin—peripheral nervous system neoplasm	0.000529	0.000738	CcSEcCtD
Pemetrexed—Anaphylactic shock—Cisplatin—peripheral nervous system neoplasm	0.000529	0.000738	CcSEcCtD
Pemetrexed—TYMS—Circadian rythm related genes—NTRK1—peripheral nervous system neoplasm	0.000528	0.00544	CbGpPWpGaD
Pemetrexed—DCK—Retinoblastoma (RB) in Cancer—MYC—peripheral nervous system neoplasm	0.000526	0.00541	CbGpPWpGaD
Pemetrexed—Infection—Cisplatin—peripheral nervous system neoplasm	0.000525	0.000733	CcSEcCtD
Pemetrexed—Vomiting—Topotecan—peripheral nervous system neoplasm	0.000525	0.000733	CcSEcCtD
Pemetrexed—Mood swings—Epirubicin—peripheral nervous system neoplasm	0.000523	0.000731	CcSEcCtD
Pemetrexed—Loss of consciousness—Etoposide—peripheral nervous system neoplasm	0.000522	0.000728	CcSEcCtD
Pemetrexed—Cerebrovascular accident—Doxorubicin—peripheral nervous system neoplasm	0.000522	0.000728	CcSEcCtD
Pemetrexed—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.000521	0.000727	CcSEcCtD
Pemetrexed—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.000521	0.000727	CcSEcCtD
Pemetrexed—Rash—Topotecan—peripheral nervous system neoplasm	0.000521	0.000727	CcSEcCtD
Pemetrexed—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.00052	0.000726	CcSEcCtD
Pemetrexed—Decreased appetite—Vincristine—peripheral nervous system neoplasm	0.00052	0.000726	CcSEcCtD
Pemetrexed—Nervous system disorder—Cisplatin—peripheral nervous system neoplasm	0.000519	0.000724	CcSEcCtD
Pemetrexed—Thrombocytopenia—Cisplatin—peripheral nervous system neoplasm	0.000518	0.000723	CcSEcCtD
Pemetrexed—Blood creatinine increased—Epirubicin—peripheral nervous system neoplasm	0.000518	0.000723	CcSEcCtD
Pemetrexed—Rash—Tretinoin—peripheral nervous system neoplasm	0.000516	0.000721	CcSEcCtD
Pemetrexed—Rash—Isotretinoin—peripheral nervous system neoplasm	0.000516	0.000721	CcSEcCtD
Pemetrexed—Gastrointestinal disorder—Vincristine—peripheral nervous system neoplasm	0.000516	0.000721	CcSEcCtD
Pemetrexed—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.000516	0.00072	CcSEcCtD
Pemetrexed—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.000516	0.00072	CcSEcCtD
Pemetrexed—Fatigue—Vincristine—peripheral nervous system neoplasm	0.000516	0.00072	CcSEcCtD
Pemetrexed—Vomiting—Melphalan—peripheral nervous system neoplasm	0.000514	0.000718	CcSEcCtD
Pemetrexed—Dehydration—Epirubicin—peripheral nervous system neoplasm	0.000514	0.000717	CcSEcCtD
Pemetrexed—Skin disorder—Cisplatin—peripheral nervous system neoplasm	0.000514	0.000717	CcSEcCtD
Pemetrexed—Hypertension—Etoposide—peripheral nervous system neoplasm	0.000512	0.000715	CcSEcCtD
Pemetrexed—Pain—Vincristine—peripheral nervous system neoplasm	0.000511	0.000714	CcSEcCtD
Pemetrexed—Constipation—Vincristine—peripheral nervous system neoplasm	0.000511	0.000714	CcSEcCtD
Pemetrexed—SLC46A1—Metabolism—GNS—peripheral nervous system neoplasm	0.000511	0.00526	CbGpPWpGaD
Pemetrexed—Rash—Melphalan—peripheral nervous system neoplasm	0.00051	0.000712	CcSEcCtD
Pemetrexed—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.000509	0.000711	CcSEcCtD
Pemetrexed—Gastrointestinal pain—Alitretinoin—peripheral nervous system neoplasm	0.000508	0.000709	CcSEcCtD
Pemetrexed—DCK—Epirubicin—Doxorubicin—peripheral nervous system neoplasm	0.000505	0.0256	CbGdCrCtD
Pemetrexed—Chest pain—Etoposide—peripheral nervous system neoplasm	0.000505	0.000706	CcSEcCtD
Pemetrexed—Anorexia—Cisplatin—peripheral nervous system neoplasm	0.000504	0.000704	CcSEcCtD
Pemetrexed—TYMS—Integrated Pancreatic Cancer Pathway—BDNF—peripheral nervous system neoplasm	0.000504	0.00519	CbGpPWpGaD
Pemetrexed—Unspecified disorder of skin and subcutaneous tissue—Etoposide—peripheral nervous system neoplasm	0.000502	0.000701	CcSEcCtD
Pemetrexed—Aspartate aminotransferase increased—Epirubicin—peripheral nervous system neoplasm	0.000498	0.000695	CcSEcCtD
Pemetrexed—Toxic epidermal necrolysis—Epirubicin—peripheral nervous system neoplasm	0.000498	0.000695	CcSEcCtD
Pemetrexed—TYMS—Integrated Pancreatic Cancer Pathway—ABCB1—peripheral nervous system neoplasm	0.000495	0.0051	CbGpPWpGaD
Pemetrexed—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.000493	0.000688	CcSEcCtD
Pemetrexed—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.000493	0.000688	CcSEcCtD
Pemetrexed—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	0.000491	0.000685	CcSEcCtD
Pemetrexed—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	0.000491	0.000685	CcSEcCtD
Pemetrexed—Nausea—Topotecan—peripheral nervous system neoplasm	0.00049	0.000685	CcSEcCtD
Pemetrexed—SLC46A1—Metabolism—NME1—peripheral nervous system neoplasm	0.00049	0.00504	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.000489	0.00504	CbGpPWpGaD
Pemetrexed—Gastrointestinal pain—Vincristine—peripheral nervous system neoplasm	0.000489	0.000683	CcSEcCtD
Pemetrexed—Alanine aminotransferase increased—Epirubicin—peripheral nervous system neoplasm	0.000487	0.00068	CcSEcCtD
Pemetrexed—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.000486	0.000679	CcSEcCtD
Pemetrexed—Nausea—Tretinoin—peripheral nervous system neoplasm	0.000486	0.000679	CcSEcCtD
Pemetrexed—DHFR—E2F transcription factor network—MYC—peripheral nervous system neoplasm	0.000486	0.005	CbGpPWpGaD
Pemetrexed—Anaphylactic shock—Etoposide—peripheral nervous system neoplasm	0.000484	0.000676	CcSEcCtD
Pemetrexed—Mood swings—Doxorubicin—peripheral nervous system neoplasm	0.000484	0.000676	CcSEcCtD
Pemetrexed—GART—Metabolism—BCHE—peripheral nervous system neoplasm	0.000484	0.00498	CbGpPWpGaD
Pemetrexed—Musculoskeletal discomfort—Cisplatin—peripheral nervous system neoplasm	0.000482	0.000673	CcSEcCtD
Pemetrexed—Infection—Etoposide—peripheral nervous system neoplasm	0.000481	0.000672	CcSEcCtD
Pemetrexed—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.00048	0.00067	CcSEcCtD
Pemetrexed—Nausea—Melphalan—peripheral nervous system neoplasm	0.00048	0.00067	CcSEcCtD
Pemetrexed—Blood creatinine increased—Doxorubicin—peripheral nervous system neoplasm	0.000479	0.000669	CcSEcCtD
Pemetrexed—Dysphagia—Epirubicin—peripheral nervous system neoplasm	0.000478	0.000667	CcSEcCtD
Pemetrexed—Dehydration—Doxorubicin—peripheral nervous system neoplasm	0.000475	0.000664	CcSEcCtD
Pemetrexed—Thrombocytopenia—Etoposide—peripheral nervous system neoplasm	0.000474	0.000662	CcSEcCtD
Pemetrexed—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.000473	0.00066	CcSEcCtD
Pemetrexed—Body temperature increased—Vincristine—peripheral nervous system neoplasm	0.000473	0.00066	CcSEcCtD
Pemetrexed—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	0.000471	0.000658	CcSEcCtD
Pemetrexed—DCK—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.000471	0.00485	CbGpPWpGaD
Pemetrexed—SLC46A1—Metabolism—COX2—peripheral nervous system neoplasm	0.000471	0.00485	CbGpPWpGaD
Pemetrexed—Skin disorder—Etoposide—peripheral nervous system neoplasm	0.000471	0.000657	CcSEcCtD
Pemetrexed—Pancreatitis—Epirubicin—peripheral nervous system neoplasm	0.000468	0.000654	CcSEcCtD
Pemetrexed—Angina pectoris—Epirubicin—peripheral nervous system neoplasm	0.000465	0.000649	CcSEcCtD
Pemetrexed—GART—Metabolism—SLC2A1—peripheral nervous system neoplasm	0.000462	0.00475	CbGpPWpGaD
Pemetrexed—Anorexia—Etoposide—peripheral nervous system neoplasm	0.000462	0.000645	CcSEcCtD
Pemetrexed—Toxic epidermal necrolysis—Doxorubicin—peripheral nervous system neoplasm	0.00046	0.000643	CcSEcCtD
Pemetrexed—Aspartate aminotransferase increased—Doxorubicin—peripheral nervous system neoplasm	0.00046	0.000643	CcSEcCtD
Pemetrexed—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	0.00046	0.000642	CcSEcCtD
Pemetrexed—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.000458	0.000639	CcSEcCtD
Pemetrexed—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.000457	0.000638	CcSEcCtD
Pemetrexed—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	0.000457	0.000637	CcSEcCtD
Pemetrexed—GART—Metabolism—TH—peripheral nervous system neoplasm	0.000455	0.00469	CbGpPWpGaD
Pemetrexed—Pancytopenia—Epirubicin—peripheral nervous system neoplasm	0.000454	0.000633	CcSEcCtD
Pemetrexed—Pain—Cisplatin—peripheral nervous system neoplasm	0.000452	0.000631	CcSEcCtD
Pemetrexed—Alanine aminotransferase increased—Doxorubicin—peripheral nervous system neoplasm	0.000451	0.000629	CcSEcCtD
Pemetrexed—Neutropenia—Epirubicin—peripheral nervous system neoplasm	0.000447	0.000623	CcSEcCtD
Pemetrexed—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.000445	0.000622	CcSEcCtD
Pemetrexed—Dysphagia—Doxorubicin—peripheral nervous system neoplasm	0.000442	0.000617	CcSEcCtD
Pemetrexed—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.000441	0.000615	CcSEcCtD
Pemetrexed—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.000439	0.000613	CcSEcCtD
Pemetrexed—DHFR—Mitotic G1-G1/S phases—CDKN2A—peripheral nervous system neoplasm	0.000439	0.00452	CbGpPWpGaD
Pemetrexed—Pancreatitis—Doxorubicin—peripheral nervous system neoplasm	0.000433	0.000605	CcSEcCtD
Pemetrexed—DHFR—Folate Metabolism—TP53—peripheral nervous system neoplasm	0.000433	0.00445	CbGpPWpGaD
Pemetrexed—Dyspnoea—Etoposide—peripheral nervous system neoplasm	0.000432	0.000603	CcSEcCtD
Pemetrexed—DCK—Retinoblastoma (RB) in Cancer—TP53—peripheral nervous system neoplasm	0.000432	0.00444	CbGpPWpGaD
Pemetrexed—Angina pectoris—Doxorubicin—peripheral nervous system neoplasm	0.00043	0.000601	CcSEcCtD
Pemetrexed—Asthenia—Vincristine—peripheral nervous system neoplasm	0.000429	0.000599	CcSEcCtD
Pemetrexed—SLC46A1—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	0.000429	0.00441	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—PPP3R1—peripheral nervous system neoplasm	0.000427	0.00439	CbGpPWpGaD
Pemetrexed—Infestation—Epirubicin—peripheral nervous system neoplasm	0.000426	0.000594	CcSEcCtD
Pemetrexed—Infestation NOS—Epirubicin—peripheral nervous system neoplasm	0.000426	0.000594	CcSEcCtD
Pemetrexed—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000426	0.000594	CcSEcCtD
Pemetrexed—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000425	0.000593	CcSEcCtD
Pemetrexed—TYMS—E2F transcription factor network—MYC—peripheral nervous system neoplasm	0.000424	0.00437	CbGpPWpGaD
Pemetrexed—DHFR—Retinoblastoma (RB) in Cancer—MYC—peripheral nervous system neoplasm	0.000423	0.00435	CbGpPWpGaD
Pemetrexed—SLC29A1—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	0.000422	0.00435	CbGpPWpGaD
Pemetrexed—Stevens-Johnson syndrome—Epirubicin—peripheral nervous system neoplasm	0.000422	0.000589	CcSEcCtD
Pemetrexed—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000422	0.000589	CcSEcCtD
Pemetrexed—Decreased appetite—Etoposide—peripheral nervous system neoplasm	0.000421	0.000588	CcSEcCtD
Pemetrexed—SLC46A1—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	0.00042	0.00433	CbGpPWpGaD
Pemetrexed—Pancytopenia—Doxorubicin—peripheral nervous system neoplasm	0.00042	0.000586	CcSEcCtD
Pemetrexed—Renal failure—Epirubicin—peripheral nervous system neoplasm	0.000419	0.000584	CcSEcCtD
Pemetrexed—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.000418	0.000584	CcSEcCtD
Pemetrexed—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.000418	0.000584	CcSEcCtD
Pemetrexed—Fatigue—Etoposide—peripheral nervous system neoplasm	0.000418	0.000583	CcSEcCtD
Pemetrexed—Neuropathy peripheral—Epirubicin—peripheral nervous system neoplasm	0.000417	0.000583	CcSEcCtD
Pemetrexed—Stomatitis—Epirubicin—peripheral nervous system neoplasm	0.000415	0.000579	CcSEcCtD
Pemetrexed—Constipation—Etoposide—peripheral nervous system neoplasm	0.000414	0.000578	CcSEcCtD
Pemetrexed—Pain—Etoposide—peripheral nervous system neoplasm	0.000414	0.000578	CcSEcCtD
Pemetrexed—Conjunctivitis—Epirubicin—peripheral nervous system neoplasm	0.000414	0.000578	CcSEcCtD
Pemetrexed—Neutropenia—Doxorubicin—peripheral nervous system neoplasm	0.000413	0.000577	CcSEcCtD
Pemetrexed—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.00041	0.000573	CcSEcCtD
Pemetrexed—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.000409	0.000571	CcSEcCtD
Pemetrexed—Hepatobiliary disease—Epirubicin—peripheral nervous system neoplasm	0.000403	0.000562	CcSEcCtD
Pemetrexed—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000398	0.000555	CcSEcCtD
Pemetrexed—Agranulocytosis—Epirubicin—peripheral nervous system neoplasm	0.000397	0.000555	CcSEcCtD
Pemetrexed—ATIC—Metabolism—ENO2—peripheral nervous system neoplasm	0.000397	0.00409	CbGpPWpGaD
Pemetrexed—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.000396	0.000553	CcSEcCtD
Pemetrexed—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000395	0.000552	CcSEcCtD
Pemetrexed—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000395	0.000551	CcSEcCtD
Pemetrexed—Infestation NOS—Doxorubicin—peripheral nervous system neoplasm	0.000394	0.00055	CcSEcCtD
Pemetrexed—Infestation—Doxorubicin—peripheral nervous system neoplasm	0.000394	0.00055	CcSEcCtD
Pemetrexed—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000391	0.000546	CcSEcCtD
Pemetrexed—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000391	0.000546	CcSEcCtD
Pemetrexed—Stevens-Johnson syndrome—Doxorubicin—peripheral nervous system neoplasm	0.000391	0.000545	CcSEcCtD
Pemetrexed—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.00039	0.000544	CcSEcCtD
Pemetrexed—Renal failure—Doxorubicin—peripheral nervous system neoplasm	0.000387	0.000541	CcSEcCtD
Pemetrexed—Neuropathy peripheral—Doxorubicin—peripheral nervous system neoplasm	0.000386	0.000539	CcSEcCtD
Pemetrexed—Urticaria—Etoposide—peripheral nervous system neoplasm	0.000385	0.000537	CcSEcCtD
Pemetrexed—Stomatitis—Doxorubicin—peripheral nervous system neoplasm	0.000384	0.000536	CcSEcCtD
Pemetrexed—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.000383	0.000535	CcSEcCtD
Pemetrexed—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.000383	0.000535	CcSEcCtD
Pemetrexed—Conjunctivitis—Doxorubicin—peripheral nervous system neoplasm	0.000383	0.000535	CcSEcCtD
Pemetrexed—TYMS—Mitotic G1-G1/S phases—CDKN2A—peripheral nervous system neoplasm	0.000383	0.00394	CbGpPWpGaD
Pemetrexed—Hepatitis—Epirubicin—peripheral nervous system neoplasm	0.000382	0.000534	CcSEcCtD
Pemetrexed—Vomiting—Vincristine—peripheral nervous system neoplasm	0.00038	0.000531	CcSEcCtD
Pemetrexed—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000379	0.00053	CcSEcCtD
Pemetrexed—Pharyngitis—Epirubicin—peripheral nervous system neoplasm	0.000379	0.00053	CcSEcCtD
Pemetrexed—DHFR—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.000379	0.0039	CbGpPWpGaD
Pemetrexed—Urinary tract disorder—Epirubicin—peripheral nervous system neoplasm	0.000377	0.000527	CcSEcCtD
Pemetrexed—Rash—Vincristine—peripheral nervous system neoplasm	0.000377	0.000526	CcSEcCtD
Pemetrexed—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000377	0.000526	CcSEcCtD
Pemetrexed—Urethral disorder—Epirubicin—peripheral nervous system neoplasm	0.000375	0.000523	CcSEcCtD
Pemetrexed—DHFR—Cell Cycle, Mitotic—AURKA—peripheral nervous system neoplasm	0.000375	0.00385	CbGpPWpGaD
Pemetrexed—Hepatobiliary disease—Doxorubicin—peripheral nervous system neoplasm	0.000373	0.00052	CcSEcCtD
Pemetrexed—GART—Metabolism—GNAS—peripheral nervous system neoplasm	0.000372	0.00383	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—ENO2—peripheral nervous system neoplasm	0.00037	0.0038	CbGpPWpGaD
Pemetrexed—TYMS—Retinoblastoma (RB) in Cancer—MYC—peripheral nervous system neoplasm	0.000369	0.00379	CbGpPWpGaD
Pemetrexed—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000369	0.000515	CcSEcCtD
Pemetrexed—Agranulocytosis—Doxorubicin—peripheral nervous system neoplasm	0.000368	0.000513	CcSEcCtD
Pemetrexed—GART—Metabolism—ABCB1—peripheral nervous system neoplasm	0.000365	0.00375	CbGpPWpGaD
Pemetrexed—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.000362	0.000505	CcSEcCtD
Pemetrexed—Erythema multiforme—Epirubicin—peripheral nervous system neoplasm	0.000361	0.000505	CcSEcCtD
Pemetrexed—Eye disorder—Epirubicin—peripheral nervous system neoplasm	0.000357	0.000499	CcSEcCtD
Pemetrexed—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.000357	0.000498	CcSEcCtD
Pemetrexed—Nausea—Vincristine—peripheral nervous system neoplasm	0.000355	0.000496	CcSEcCtD
Pemetrexed—Hepatitis—Doxorubicin—peripheral nervous system neoplasm	0.000354	0.000494	CcSEcCtD
Pemetrexed—DHFR—G1/S Transition—MYC—peripheral nervous system neoplasm	0.000353	0.00363	CbGpPWpGaD
Pemetrexed—Pharyngitis—Doxorubicin—peripheral nervous system neoplasm	0.000351	0.00049	CcSEcCtD
Pemetrexed—Urinary tract disorder—Doxorubicin—peripheral nervous system neoplasm	0.000349	0.000488	CcSEcCtD
Pemetrexed—Asthenia—Etoposide—peripheral nervous system neoplasm	0.000348	0.000485	CcSEcCtD
Pemetrexed—DHFR—Retinoblastoma (RB) in Cancer—TP53—peripheral nervous system neoplasm	0.000347	0.00357	CbGpPWpGaD
Pemetrexed—Urethral disorder—Doxorubicin—peripheral nervous system neoplasm	0.000347	0.000484	CcSEcCtD
Pemetrexed—Pruritus—Etoposide—peripheral nervous system neoplasm	0.000343	0.000479	CcSEcCtD
Pemetrexed—Arrhythmia—Epirubicin—peripheral nervous system neoplasm	0.000341	0.000477	CcSEcCtD
Pemetrexed—DCK—Metabolism—GNS—peripheral nervous system neoplasm	0.000341	0.00351	CbGpPWpGaD
Pemetrexed—SLC29A1—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	0.00034	0.0035	CbGpPWpGaD
Pemetrexed—Alopecia—Epirubicin—peripheral nervous system neoplasm	0.000338	0.000472	CcSEcCtD
Pemetrexed—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000336	0.000469	CcSEcCtD
Pemetrexed—ATIC—Metabolism—BCHE—peripheral nervous system neoplasm	0.000336	0.00345	CbGpPWpGaD
Pemetrexed—DHFR—Cell Cycle—AURKA—peripheral nervous system neoplasm	0.000335	0.00345	CbGpPWpGaD
Pemetrexed—Erythema multiforme—Doxorubicin—peripheral nervous system neoplasm	0.000334	0.000467	CcSEcCtD
Pemetrexed—SLC29A1—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	0.000333	0.00343	CbGpPWpGaD
Pemetrexed—Rash—Cisplatin—peripheral nervous system neoplasm	0.000333	0.000465	CcSEcCtD
Pemetrexed—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000333	0.000465	CcSEcCtD
Pemetrexed—Malnutrition—Epirubicin—peripheral nervous system neoplasm	0.000333	0.000465	CcSEcCtD
Pemetrexed—Erythema—Epirubicin—peripheral nervous system neoplasm	0.000333	0.000465	CcSEcCtD
Pemetrexed—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.000331	0.000463	CcSEcCtD
Pemetrexed—TYMS—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.000331	0.0034	CbGpPWpGaD
Pemetrexed—Eye disorder—Doxorubicin—peripheral nervous system neoplasm	0.000331	0.000461	CcSEcCtD
Pemetrexed—DHFR—Disease—GNS—peripheral nervous system neoplasm	0.000327	0.00337	CbGpPWpGaD
Pemetrexed—TYMS—Cell Cycle, Mitotic—AURKA—peripheral nervous system neoplasm	0.000327	0.00336	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—NME1—peripheral nervous system neoplasm	0.000327	0.00336	CbGpPWpGaD
Pemetrexed—Dysgeusia—Epirubicin—peripheral nervous system neoplasm	0.000326	0.000455	CcSEcCtD
Pemetrexed—Dizziness—Etoposide—peripheral nervous system neoplasm	0.00032	0.000447	CcSEcCtD
Pemetrexed—ATIC—Metabolism—SLC2A1—peripheral nervous system neoplasm	0.00032	0.0033	CbGpPWpGaD
Pemetrexed—Arrhythmia—Doxorubicin—peripheral nervous system neoplasm	0.000316	0.000441	CcSEcCtD
Pemetrexed—ATIC—Metabolism—TH—peripheral nervous system neoplasm	0.000316	0.00325	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—COX2—peripheral nervous system neoplasm	0.000315	0.00324	CbGpPWpGaD
Pemetrexed—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000314	0.000439	CcSEcCtD
Pemetrexed—Alopecia—Doxorubicin—peripheral nervous system neoplasm	0.000313	0.000436	CcSEcCtD
Pemetrexed—SLC46A1—Metabolism—ENO2—peripheral nervous system neoplasm	0.000309	0.00319	CbGpPWpGaD
Pemetrexed—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000308	0.00043	CcSEcCtD
Pemetrexed—Malnutrition—Doxorubicin—peripheral nervous system neoplasm	0.000308	0.00043	CcSEcCtD
Pemetrexed—Erythema—Doxorubicin—peripheral nervous system neoplasm	0.000308	0.00043	CcSEcCtD
Pemetrexed—TYMS—G1/S Transition—MYC—peripheral nervous system neoplasm	0.000308	0.00317	CbGpPWpGaD
Pemetrexed—Anaemia—Epirubicin—peripheral nervous system neoplasm	0.000308	0.000429	CcSEcCtD
Pemetrexed—Rash—Etoposide—peripheral nervous system neoplasm	0.000305	0.000426	CcSEcCtD
Pemetrexed—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000305	0.000426	CcSEcCtD
Pemetrexed—TYMS—Retinoblastoma (RB) in Cancer—TP53—peripheral nervous system neoplasm	0.000303	0.00312	CbGpPWpGaD
Pemetrexed—Dysgeusia—Doxorubicin—peripheral nervous system neoplasm	0.000301	0.000421	CcSEcCtD
Pemetrexed—DHFR—Cell Cycle—CHEK2—peripheral nervous system neoplasm	0.000299	0.00308	CbGpPWpGaD
Pemetrexed—Syncope—Epirubicin—peripheral nervous system neoplasm	0.000298	0.000417	CcSEcCtD
Pemetrexed—SLC46A1—Disease—SLC2A1—peripheral nervous system neoplasm	0.000298	0.00307	CbGpPWpGaD
Pemetrexed—Leukopenia—Epirubicin—peripheral nervous system neoplasm	0.000298	0.000416	CcSEcCtD
Pemetrexed—DHFR—Mitotic G1-G1/S phases—MYC—peripheral nervous system neoplasm	0.000297	0.00306	CbGpPWpGaD
Pemetrexed—Loss of consciousness—Epirubicin—peripheral nervous system neoplasm	0.000292	0.000408	CcSEcCtD
Pemetrexed—TYMS—Cell Cycle—AURKA—peripheral nervous system neoplasm	0.000292	0.00301	CbGpPWpGaD
Pemetrexed—Nausea—Etoposide—peripheral nervous system neoplasm	0.000288	0.000402	CcSEcCtD
Pemetrexed—Hypertension—Epirubicin—peripheral nervous system neoplasm	0.000287	0.000401	CcSEcCtD
Pemetrexed—Anaemia—Doxorubicin—peripheral nervous system neoplasm	0.000285	0.000397	CcSEcCtD
Pemetrexed—Chest pain—Epirubicin—peripheral nervous system neoplasm	0.000283	0.000395	CcSEcCtD
Pemetrexed—Arthralgia—Epirubicin—peripheral nervous system neoplasm	0.000283	0.000395	CcSEcCtD
Pemetrexed—Myalgia—Epirubicin—peripheral nervous system neoplasm	0.000283	0.000395	CcSEcCtD
Pemetrexed—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	0.000281	0.000393	CcSEcCtD
Pemetrexed—TYMS—Integrated Pancreatic Cancer Pathway—ERBB2—peripheral nervous system neoplasm	0.000277	0.00285	CbGpPWpGaD
Pemetrexed—Syncope—Doxorubicin—peripheral nervous system neoplasm	0.000276	0.000385	CcSEcCtD
Pemetrexed—Leukopenia—Doxorubicin—peripheral nervous system neoplasm	0.000276	0.000385	CcSEcCtD
Pemetrexed—DHFR—Metabolism—GNS—peripheral nervous system neoplasm	0.000274	0.00282	CbGpPWpGaD
Pemetrexed—Oedema—Epirubicin—peripheral nervous system neoplasm	0.000272	0.000379	CcSEcCtD
Pemetrexed—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	0.000272	0.000379	CcSEcCtD
Pemetrexed—Loss of consciousness—Doxorubicin—peripheral nervous system neoplasm	0.000271	0.000378	CcSEcCtD
Pemetrexed—Infection—Epirubicin—peripheral nervous system neoplasm	0.00027	0.000377	CcSEcCtD
Pemetrexed—Shock—Epirubicin—peripheral nervous system neoplasm	0.000267	0.000373	CcSEcCtD
Pemetrexed—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	0.000266	0.000372	CcSEcCtD
Pemetrexed—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	0.000266	0.000371	CcSEcCtD
Pemetrexed—Hypertension—Doxorubicin—peripheral nervous system neoplasm	0.000266	0.000371	CcSEcCtD
Pemetrexed—Skin disorder—Epirubicin—peripheral nervous system neoplasm	0.000264	0.000368	CcSEcCtD
Pemetrexed—DHFR—Metabolism—NME1—peripheral nervous system neoplasm	0.000263	0.0027	CbGpPWpGaD
Pemetrexed—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	0.000262	0.000366	CcSEcCtD
Pemetrexed—Myalgia—Doxorubicin—peripheral nervous system neoplasm	0.000262	0.000366	CcSEcCtD
Pemetrexed—Chest pain—Doxorubicin—peripheral nervous system neoplasm	0.000262	0.000366	CcSEcCtD
Pemetrexed—SLC46A1—Metabolism—BCHE—peripheral nervous system neoplasm	0.000261	0.00269	CbGpPWpGaD
Pemetrexed—TYMS—Cell Cycle—CHEK2—peripheral nervous system neoplasm	0.000261	0.00269	CbGpPWpGaD
Pemetrexed—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	0.00026	0.000363	CcSEcCtD
Pemetrexed—TYMS—Mitotic G1-G1/S phases—MYC—peripheral nervous system neoplasm	0.000259	0.00267	CbGpPWpGaD
Pemetrexed—Anorexia—Epirubicin—peripheral nervous system neoplasm	0.000259	0.000361	CcSEcCtD
Pemetrexed—ATIC—Metabolism—GNAS—peripheral nervous system neoplasm	0.000258	0.00265	CbGpPWpGaD
Pemetrexed—ATIC—Metabolism—ABCB1—peripheral nervous system neoplasm	0.000253	0.0026	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—COX2—peripheral nervous system neoplasm	0.000253	0.0026	CbGpPWpGaD
Pemetrexed—TYMS—Integrated Pancreatic Cancer Pathway—CASP3—peripheral nervous system neoplasm	0.000252	0.00259	CbGpPWpGaD
Pemetrexed—Oedema—Doxorubicin—peripheral nervous system neoplasm	0.000251	0.000351	CcSEcCtD
Pemetrexed—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	0.000251	0.000351	CcSEcCtD
Pemetrexed—Infection—Doxorubicin—peripheral nervous system neoplasm	0.00025	0.000349	CcSEcCtD
Pemetrexed—SLC46A1—Metabolism—SLC2A1—peripheral nervous system neoplasm	0.000249	0.00257	CbGpPWpGaD
Pemetrexed—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	0.000247	0.000345	CcSEcCtD
Pemetrexed—Shock—Doxorubicin—peripheral nervous system neoplasm	0.000247	0.000345	CcSEcCtD
Pemetrexed—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000246	0.000344	CcSEcCtD
Pemetrexed—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	0.000246	0.000343	CcSEcCtD
Pemetrexed—SLC46A1—Metabolism—TH—peripheral nervous system neoplasm	0.000246	0.00253	CbGpPWpGaD
Pemetrexed—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	0.000244	0.000341	CcSEcCtD
Pemetrexed—DHFR—Cell Cycle, Mitotic—BIRC5—peripheral nervous system neoplasm	0.000243	0.0025	CbGpPWpGaD
Pemetrexed—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	0.000242	0.000338	CcSEcCtD
Pemetrexed—Anorexia—Doxorubicin—peripheral nervous system neoplasm	0.00024	0.000334	CcSEcCtD
Pemetrexed—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	0.000239	0.000334	CcSEcCtD
Pemetrexed—TYMS—Metabolism—GNS—peripheral nervous system neoplasm	0.000239	0.00246	CbGpPWpGaD
Pemetrexed—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	0.000236	0.00033	CcSEcCtD
Pemetrexed—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000234	0.000327	CcSEcCtD
Pemetrexed—Fatigue—Epirubicin—peripheral nervous system neoplasm	0.000234	0.000327	CcSEcCtD
Pemetrexed—Constipation—Epirubicin—peripheral nervous system neoplasm	0.000232	0.000324	CcSEcCtD
Pemetrexed—Pain—Epirubicin—peripheral nervous system neoplasm	0.000232	0.000324	CcSEcCtD
Pemetrexed—TYMS—Metabolism—NME1—peripheral nervous system neoplasm	0.000229	0.00236	CbGpPWpGaD
Pemetrexed—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000229	0.00032	CcSEcCtD
Pemetrexed—DHFR—Disease—PPP3R1—peripheral nervous system neoplasm	0.000229	0.00235	CbGpPWpGaD
Pemetrexed—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	0.000224	0.000313	CcSEcCtD
Pemetrexed—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	0.000222	0.00031	CcSEcCtD
Pemetrexed—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	0.000221	0.000309	CcSEcCtD
Pemetrexed—TYMS—Metabolism—COX2—peripheral nervous system neoplasm	0.000221	0.00227	CbGpPWpGaD
Pemetrexed—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	0.000218	0.000305	CcSEcCtD
Pemetrexed—DHFR—Cell Cycle—BIRC5—peripheral nervous system neoplasm	0.000217	0.00223	CbGpPWpGaD
Pemetrexed—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000217	0.000303	CcSEcCtD
Pemetrexed—Fatigue—Doxorubicin—peripheral nervous system neoplasm	0.000217	0.000302	CcSEcCtD
Pemetrexed—Urticaria—Epirubicin—peripheral nervous system neoplasm	0.000216	0.000301	CcSEcCtD
Pemetrexed—Constipation—Doxorubicin—peripheral nervous system neoplasm	0.000215	0.0003	CcSEcCtD
Pemetrexed—Pain—Doxorubicin—peripheral nervous system neoplasm	0.000215	0.0003	CcSEcCtD
Pemetrexed—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	0.000215	0.0003	CcSEcCtD
Pemetrexed—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	0.000215	0.0003	CcSEcCtD
Pemetrexed—TYMS—Cell Cycle, Mitotic—BIRC5—peripheral nervous system neoplasm	0.000212	0.00218	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—ENO2—peripheral nervous system neoplasm	0.000206	0.00213	CbGpPWpGaD
Pemetrexed—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	0.000205	0.000287	CcSEcCtD
Pemetrexed—SLC46A1—Metabolism—GNAS—peripheral nervous system neoplasm	0.000201	0.00207	CbGpPWpGaD
Pemetrexed—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	0.0002	0.000279	CcSEcCtD
Pemetrexed—Urticaria—Doxorubicin—peripheral nervous system neoplasm	0.0002	0.000279	CcSEcCtD
Pemetrexed—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	0.000199	0.000277	CcSEcCtD
Pemetrexed—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	0.000199	0.000277	CcSEcCtD
Pemetrexed—DHFR—Disease—ENO2—peripheral nervous system neoplasm	0.000198	0.00204	CbGpPWpGaD
Pemetrexed—SLC46A1—Metabolism—ABCB1—peripheral nervous system neoplasm	0.000197	0.00203	CbGpPWpGaD
Pemetrexed—TYMS—Integrated Pancreatic Cancer Pathway—MYC—peripheral nervous system neoplasm	0.000197	0.00202	CbGpPWpGaD
Pemetrexed—Asthenia—Epirubicin—peripheral nervous system neoplasm	0.000195	0.000272	CcSEcCtD
Pemetrexed—Pruritus—Epirubicin—peripheral nervous system neoplasm	0.000192	0.000268	CcSEcCtD
Pemetrexed—TYMS—Cell Cycle—BIRC5—peripheral nervous system neoplasm	0.000189	0.00195	CbGpPWpGaD
Pemetrexed—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	0.000186	0.000259	CcSEcCtD
Pemetrexed—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	0.000185	0.000258	CcSEcCtD
Pemetrexed—Asthenia—Doxorubicin—peripheral nervous system neoplasm	0.00018	0.000252	CcSEcCtD
Pemetrexed—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.00018	0.000251	CcSEcCtD
Pemetrexed—Pruritus—Doxorubicin—peripheral nervous system neoplasm	0.000178	0.000248	CcSEcCtD
Pemetrexed—DCK—Metabolism—BCHE—peripheral nervous system neoplasm	0.000174	0.0018	CbGpPWpGaD
Pemetrexed—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.000173	0.000241	CcSEcCtD
Pemetrexed—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	0.000172	0.00024	CcSEcCtD
Pemetrexed—Rash—Epirubicin—peripheral nervous system neoplasm	0.000171	0.000239	CcSEcCtD
Pemetrexed—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.000171	0.000239	CcSEcCtD
Pemetrexed—SLC46A1—Disease—PTPN11—peripheral nervous system neoplasm	0.000167	0.00171	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—SLC2A1—peripheral nervous system neoplasm	0.000166	0.00171	CbGpPWpGaD
Pemetrexed—Dizziness—Doxorubicin—peripheral nervous system neoplasm	0.000166	0.000232	CcSEcCtD
Pemetrexed—DHFR—Metabolism—ENO2—peripheral nervous system neoplasm	0.000166	0.00171	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—TH—peripheral nervous system neoplasm	0.000164	0.00169	CbGpPWpGaD
Pemetrexed—TYMS—Integrated Pancreatic Cancer Pathway—TP53—peripheral nervous system neoplasm	0.000161	0.00166	CbGpPWpGaD
Pemetrexed—Nausea—Epirubicin—peripheral nervous system neoplasm	0.000161	0.000225	CcSEcCtD
Pemetrexed—DHFR—Cell Cycle, Mitotic—CDKN2A—peripheral nervous system neoplasm	0.000161	0.00166	CbGpPWpGaD
Pemetrexed—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.00016	0.000223	CcSEcCtD
Pemetrexed—DHFR—Disease—SLC2A1—peripheral nervous system neoplasm	0.00016	0.00164	CbGpPWpGaD
Pemetrexed—Rash—Doxorubicin—peripheral nervous system neoplasm	0.000158	0.000221	CcSEcCtD
Pemetrexed—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.000158	0.000221	CcSEcCtD
Pemetrexed—TYMS—Circadian rythm related genes—TP53—peripheral nervous system neoplasm	0.000155	0.00159	CbGpPWpGaD
Pemetrexed—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.000149	0.000208	CcSEcCtD
Pemetrexed—TYMS—Metabolism—ENO2—peripheral nervous system neoplasm	0.000145	0.00149	CbGpPWpGaD
Pemetrexed—DHFR—Cell Cycle—CDKN2A—peripheral nervous system neoplasm	0.000144	0.00148	CbGpPWpGaD
Pemetrexed—TYMS—Cell Cycle, Mitotic—CDKN2A—peripheral nervous system neoplasm	0.00014	0.00145	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—BCHE—peripheral nervous system neoplasm	0.00014	0.00144	CbGpPWpGaD
Pemetrexed—TYMS—Integrated Pancreatic Cancer Pathway—AKT1—peripheral nervous system neoplasm	0.000136	0.0014	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—GNAS—peripheral nervous system neoplasm	0.000134	0.00138	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—SLC2A1—peripheral nervous system neoplasm	0.000134	0.00138	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—TH—peripheral nervous system neoplasm	0.000132	0.00136	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—ERBB2—peripheral nervous system neoplasm	0.000132	0.00135	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—ABCB1—peripheral nervous system neoplasm	0.000131	0.00135	CbGpPWpGaD
Pemetrexed—TYMS—Cell Cycle—CDKN2A—peripheral nervous system neoplasm	0.000126	0.00129	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—BCHE—peripheral nervous system neoplasm	0.000122	0.00126	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—SLC2A1—peripheral nervous system neoplasm	0.000117	0.0012	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—TH—peripheral nervous system neoplasm	0.000115	0.00118	CbGpPWpGaD
Pemetrexed—DHFR—Cell Cycle, Mitotic—MYC—peripheral nervous system neoplasm	0.000109	0.00112	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—GNAS—peripheral nervous system neoplasm	0.000108	0.00111	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—ABCB1—peripheral nervous system neoplasm	0.000106	0.00109	CbGpPWpGaD
Pemetrexed—GART—Metabolism—AKT1—peripheral nervous system neoplasm	0.0001	0.00103	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—NRAS—peripheral nervous system neoplasm	0.0001	0.00103	CbGpPWpGaD
Pemetrexed—DHFR—Cell Cycle—MYC—peripheral nervous system neoplasm	9.75e-05	0.001	CbGpPWpGaD
Pemetrexed—TYMS—Cell Cycle, Mitotic—MYC—peripheral nervous system neoplasm	9.51e-05	0.000979	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—GNAS—peripheral nervous system neoplasm	9.39e-05	0.000966	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—MYC—peripheral nervous system neoplasm	9.33e-05	0.00096	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—ABCB1—peripheral nervous system neoplasm	9.21e-05	0.000948	CbGpPWpGaD
Pemetrexed—DHFR—Disease—PTPN11—peripheral nervous system neoplasm	8.93e-05	0.000919	CbGpPWpGaD
Pemetrexed—TYMS—Cell Cycle—MYC—peripheral nervous system neoplasm	8.51e-05	0.000876	CbGpPWpGaD
Pemetrexed—DHFR—Cell Cycle—TP53—peripheral nervous system neoplasm	8.01e-05	0.000824	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—HRAS—peripheral nervous system neoplasm	7.33e-05	0.000754	CbGpPWpGaD
Pemetrexed—DHFR—Disease—ERBB2—peripheral nervous system neoplasm	7.06e-05	0.000726	CbGpPWpGaD
Pemetrexed—TYMS—Cell Cycle—TP53—peripheral nervous system neoplasm	6.99e-05	0.000719	CbGpPWpGaD
Pemetrexed—ATIC—Metabolism—AKT1—peripheral nervous system neoplasm	6.95e-05	0.000716	CbGpPWpGaD
Pemetrexed—SLC46A1—Disease—AKT1—peripheral nervous system neoplasm	6.47e-05	0.000666	CbGpPWpGaD
Pemetrexed—SLC46A1—Metabolism—AKT1—peripheral nervous system neoplasm	5.42e-05	0.000558	CbGpPWpGaD
Pemetrexed—DHFR—Disease—NRAS—peripheral nervous system neoplasm	5.37e-05	0.000553	CbGpPWpGaD
Pemetrexed—DHFR—Disease—MYC—peripheral nervous system neoplasm	5e-05	0.000515	CbGpPWpGaD
Pemetrexed—DHFR—Disease—HRAS—peripheral nervous system neoplasm	3.93e-05	0.000404	CbGpPWpGaD
Pemetrexed—DCK—Metabolism—AKT1—peripheral nervous system neoplasm	3.61e-05	0.000372	CbGpPWpGaD
Pemetrexed—DHFR—Disease—AKT1—peripheral nervous system neoplasm	3.47e-05	0.000357	CbGpPWpGaD
Pemetrexed—DHFR—Metabolism—AKT1—peripheral nervous system neoplasm	2.9e-05	0.000299	CbGpPWpGaD
Pemetrexed—TYMS—Metabolism—AKT1—peripheral nervous system neoplasm	2.53e-05	0.000261	CbGpPWpGaD
